Esperion appoints J. Martin Carroll as Chairperson of the Board and new director

Esperion Therapeutics, Inc.

J. Martin Carroll appointed to fill newly created vacancy; board expands from 9 to 10 directors.
Carroll named Chairperson of the Board effective June 1, 2022.
Carroll previously served as President/CEO of Boehringer Ingelheim Corporation and Merck & Co. veteran.
Esperion reiterates expectation for CLEAR Outcomes topline data in Q1 2023.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

J. Martin Carroll

Chairperson of the Board

ESPR · Esperion Therapeutics, Inc.

Effective: 2022-06-01
Filed: June 1, 2022, 7:59 PM ET

On June 1, 2022, the Board of Directors (the “Board”) of Esperion Therapeutics, Inc (the “Company”) elected J. Martin Carroll to fill in the newly created vacancy on the Board resulting from an increase in the size of the Board from nine (9) directors to ten (10) directors, effective June 1, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

J. Martin Carroll was appointed as Chairperson of the Board at Esperion Therapeutics, Inc..

Action: appointed
Role: Chairperson of the Board

Exact text from the filing

On June 1, 2022, the Board of Directors (the “Board”) of Esperion Therapeutics, Inc (the “Company”) elected J. Martin Carroll to fill in the newly created vacancy on the Board resulting from an increase in the size of the Board from nine (9) directors to ten (10) directors, effective June 1, 2022.

View on SEC.gov

Esperion Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-22-015897

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.